Gu Zhan

1.7k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Gu Zhan is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Gu Zhan has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Organic Chemistry, 10 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Gu Zhan's work include Catalytic C–H Functionalization Methods (16 papers), Synthesis and Catalytic Reactions (12 papers) and Asymmetric Synthesis and Catalysis (11 papers). Gu Zhan is often cited by papers focused on Catalytic C–H Functionalization Methods (16 papers), Synthesis and Catalytic Reactions (12 papers) and Asymmetric Synthesis and Catalysis (11 papers). Gu Zhan collaborates with scholars based in China, Japan and United States. Gu Zhan's co-authors include Zhaomin Hou, Masayoshi Nishiura, Bo Han, Ying‐Chun Chen, Wei Du, Huailong Teng, Ming‐Lin Shi, Qing He, Yong Luo and Shao‐Jie Lou and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Gu Zhan

46 papers receiving 1.4k citations

Hit Papers

2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gu Zhan China 22 1.1k 252 226 105 88 48 1.4k
Peter T. W. Cheng United States 19 1.1k 1.0× 302 1.2× 272 1.2× 87 0.8× 20 0.2× 49 1.5k
Jawahar L. Jat India 16 696 0.7× 228 0.9× 135 0.6× 27 0.3× 28 0.3× 43 1.0k
Carl A. Baxter United Kingdom 21 834 0.8× 236 0.9× 250 1.1× 28 0.3× 40 0.5× 55 1.4k
Fenglin Chen China 18 649 0.6× 284 1.1× 191 0.8× 158 1.5× 74 0.8× 88 1.4k
David Hageman Netherlands 15 431 0.4× 273 1.1× 67 0.3× 26 0.2× 47 0.5× 29 953
Nathan Yumibe United States 18 413 0.4× 354 1.4× 46 0.2× 74 0.7× 56 0.6× 30 1.1k
Kazutoshi Yamada Japan 18 688 0.7× 235 0.9× 73 0.3× 46 0.4× 231 2.6× 140 1.2k
Claudio F. Sturino Canada 18 644 0.6× 355 1.4× 35 0.2× 33 0.3× 34 0.4× 29 1.1k
Toshio Moriwake Japan 23 1.1k 1.0× 500 2.0× 124 0.5× 64 0.6× 22 0.3× 59 1.5k

Countries citing papers authored by Gu Zhan

Since Specialization
Citations

This map shows the geographic impact of Gu Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu Zhan more than expected).

Fields of papers citing papers by Gu Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gu Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu Zhan. The network helps show where Gu Zhan may publish in the future.

Co-authorship network of co-authors of Gu Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Gu Zhan. A scholar is included among the top collaborators of Gu Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gu Zhan. Gu Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Fu, Peng, Minru Liao, Wenke Jin, et al.. (2024). 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduction and Targeted Therapy. 9(1). 133–133. 51 indexed citations breakdown →
3.
Jia, Zhiqiang, Lei Wang, Meng Liu, et al.. (2023). T-cell Immunoglobulin and Mucin Domain 3 in Circulating Monocytes as a Novel Biomarker for Coronary Artery Disease. Journal of Cardiovascular Translational Research. 17(3). 648–656. 2 indexed citations
4.
Lu, Run, Cheng Peng, Jie Tang, et al.. (2023). A Sc(OTf)3-catalyzed one-pot two-step approach for spiro-oxindole dihydropyridine derivatives initiated by N-olefination of MBH carbonates. Organic Chemistry Frontiers. 10(9). 2294–2300. 11 indexed citations
5.
Chen, Xiaoxiao, Yizhou Chen, Meng Liu, et al.. (2023). Survival and analysis of prognostic factors for primary malignant cardiac tumors based on the SEER database. Journal of Cancer Research and Clinical Oncology. 149(17). 15687–15696. 1 indexed citations
6.
Zhao, Qian, et al.. (2023). Palladium-catalyzed asymmetric [4+2] annulation of vinyl benzoxazinanones with pyrazolone 4,5-diones to access spirobenzoxazine frameworks. Chemical Communications. 59(9). 1233–1236. 18 indexed citations
7.
Wang, Jie, et al.. (2022). Organocatalytic (5+1) benzannulation of Morita–Baylis–Hillman carbonates: synthesis of multisubstituted 4-benzylidene pyrazolones. New Journal of Chemistry. 46(24). 11617–11622. 10 indexed citations
8.
He, Xiang‐Hong, Gu Zhan, Nan Zhang, et al.. (2022). Organocatalytic asymmetric synthesis of multifunctionalized α-carboline-spirooxindole hybrids that suppressed proliferation in colorectal cancer cells. Organic Chemistry Frontiers. 9(4). 1048–1055. 35 indexed citations
9.
Qin, Rui, Qian Zhao, Xin Xie, et al.. (2022). Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. Journal of Hematology & Oncology. 15(1). 133–133. 68 indexed citations
10.
Zhao, Qian, Cheng Peng, Yuting Wang, Gu Zhan, & Bo Han. (2021). Recent progress on the construction of axial chirality through transition-metal-catalyzed benzannulation. Organic Chemistry Frontiers. 8(11). 2772–2785. 39 indexed citations
11.
Zhao, Qian, Cheng Peng, Gu Zhan, & Bo Han. (2020). Synthesis of polysubstituted arenes through organocatalytic benzannulation. RSC Advances. 10(67). 40983–41003. 29 indexed citations
12.
Zhan, Gu, Yan Bi, Fan Yuan, et al.. (2020). <p><em>FTO</em> Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population</p>. Clinical Interventions in Aging. Volume 15. 1333–1341. 13 indexed citations
13.
Zhou, Rong, Jiesheng Li, Han Wen Cheo, et al.. (2019). Visible-light-mediated deuteration of silanes with deuterium oxide. Chemical Science. 10(31). 7340–7344. 78 indexed citations
14.
Zhan, Gu, Dong Li, Ruirui Wang, et al.. (2019). Genetic variations associated with spleen-yang deficiency pattern of non-alcoholic fatty liver disease: A candidate gene study. European Journal of Integrative Medicine. 33. 101044–101044.
15.
Zhan, Gu, Dong Li, Jianying Wang, et al.. (2018). Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population. Scientific Reports. 8(1). 385–385. 42 indexed citations
16.
Zhan, Gu, Jing‐Juan Xu, Li Zhang, et al.. (2018). Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids in Health and Disease. 17(1). 289–289. 55 indexed citations
17.
Shi, Ming‐Lin, Gu Zhan, Wei Du, & Ying‐Chun Chen. (2017). Direct Asymmetric Aza-Vinylogous Mannich Reaction of Nitrones from Isatins and Ketimines. Acta Chimica Sinica. 75(10). 998–998. 6 indexed citations
18.
Zhan, Gu, et al.. (2016). Regioselective Asymmetric Formal (3+2) Cycloadditions of Nitrone Ylides from Isatins and Enals. Advanced Synthesis & Catalysis. 358(23). 3759–3764. 22 indexed citations
19.
Zhan, Gu, et al.. (2015). Study on TCM Syndrome Differentiation of Primary Liver Cancer Based on the Analysis of Latent Structural Model. Evidence-based Complementary and Alternative Medicine. 2015. 1–9. 9 indexed citations
20.
Yan, Bing, Wei Gu, Zhihui Yang, et al.. (2014). Downregulation of a long noncoding RNA-ncRuPAR contributes to tumor inhibition in colorectal cancer. Tumor Biology. 35(11). 11329–11335. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026